ornidazole

PreclinicalSmall molecule

AAssistance Publique - Hôpitaux de Paris

ornidazole is one of 37 small molecule programs targeting Irritable Bowel Syndrome. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Irritable Bowel SyndromeActive, not recruiting

Chronic ConstipationActive, not recruiting

Irritable Bowel SyndromePreclinical

Active, not recruiting

Chronic ConstipationPreclinical

Active, not recruiting

Competition

Competitive Landscape

44 competitors in Irritable Bowel Syndrome

#DrugCompanyPhaseTrials

Linzess

AbbVie

Approved

12 2

Resotran

Takeda

Approved

2 3

Cymbalta

Jazz Pharmaceuticals

Approved

2 4

Lexapro

AbbVie

Approved

1 5

Azulfidine

Nurtec

Golytely

Lyrica

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

2 9

Alinia

RRomark Laboratories L.C.

Approved

2 10

VIOKACE

AbbVie

Approved

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2029

N/ANot yet recruiting

Chronic Constipation

NCT06427863

Q1 2030

N/ANot yet recruiting

Irritable Bowel Syndrome

NCT06437041

Clinical

Trials by Indication[1]

Bowel Preparation2 trials

Mechanical Bowel Preparation and Oral Antibiotics Before Colon Cancer Surgery

Terminated·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT03475680·193 enrolled

Mechanical Bowel Preparation and Oral Antibiotics Before Rectal Cancer Surgery

Completed·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT03491540·414 enrolled

Surgical Site Infection1 trial

Intravenous Versus Combined Oral and Intravenous Antimicrobial Prophylaxis for the Prevention of Surgical Site Infection in Elective Colorectal Surgery

Completed·UUniversity Hospital, Clermont-Ferrand·Phase 3·NCT02618720·920 enrolled

Irritable Bowel Syndrome1 trial

Effect of Antibiotic Pretreatment on the Efficacy of WMT in the Treatment of Irritable Bowel Syndrome

Not yet recruiting·FFaming Zhang·N/A·NCT06437041·96 enrolled

Chronic constipation1 trial

Effect of Antibiotic Pretreatment on the Efficacy of WMT in the Treatment of Chronic Constipation

Not yet recruiting·FFaming Zhang·N/A·NCT06427863·96 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for ornidazole. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — ornidazole compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for ornidazole. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assistance Publique - Hôpitaux de Paris company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: AAssistance Publique - Hôpitaux de Paris

ornidazole

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2029

Q1 2030

Trials by Indication[1]

Bowel Preparation2 trials

Surgical Site Infection1 trial

Irritable Bowel Syndrome1 trial

Chronic constipation1 trial

References

Drug Info

Quick Facts

Related News